# Nanjing Libravo Pharmaceutical Co., Ltd. – FDA Inspection, Jul 17, 2026

Source: https://www.keypedia.com/records/fda_inspections/nanjing-libravo-pharmaceutical-co-ltd/17f2a4b9-6f56-48db-bf9b-b215040a03a0
Source feed: FDA_Inspections

> FDA inspection 1328102 of Nanjing Libravo Pharmaceutical Co., Ltd., July 17, 2026. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1328102
- Company Name: Nanjing Libravo Pharmaceutical Co., Ltd.
- Inspection Date: 2026-07-17
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 0

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/truong-x-nguyen/8f3aed17-0507-4272-a3b8-9188d761faed)

Company: https://www.keypedia.com/companies/nanjing-libravo-pharmaceutical-co-ltd/9cc39b62-902e-471d-ac5b-b494670d2a4d

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8